EGFR and lung cancer: EGFR, its oncogenic mutants, and its signaling network proteins are commonly expressed in lung cancer exosomes of different origins, which leads to the activation of translational signaling pathways and regulation of target gene expression, such as VEGF, anti-apoptotic B-cell lymphoma-extra-large, and cell cyclin-dependent kinase inhibitor P27 (145–147).